Keywords: کارسینوم هپاتوسلولار; ICC, intrahepatic cholangiocarcinoma; HCC, hepatocellular carcinoma; AGR3, anterior gradient 3; AGR2, anterior gradient 2; GPC-3, glypican-3; ROC, receiver operating characteristics; AUC, area under curveAGR3; GPC-3; Intrahepatic cholangiocarcinoma; Hepat
مقالات ISI کارسینوم هپاتوسلولار (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کارسینوم هپاتوسلولار; AOR, adjusted odds ratio; HCC, hepatocellular carcinoma; MELD, Model for End-Stage Liver Disease; SSI, surgical site infection
Keywords: کارسینوم هپاتوسلولار; DFO, deferoxamine; KTp4-Me, potassium tris(4-methyl-1-pyrazolyl)-borohydride; ROS, reactive oxygen species; HCC, hepatocellular carcinoma; DMEM, Dulbecco’s modified Eagle’s medium; FBS, fetal bovine serum; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet
Keywords: کارسینوم هپاتوسلولار; AE, adverse event; BCLC, Barcelona-Clinic Liver Cancer; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HIFU, high-intensity focused ultrasound ablation; LITT, laser-induced thermotherapy; LTX, liver transplantation; MWA, mi
Keywords: کارسینوم هپاتوسلولار; MPP3, membrane palmitoylated protein 3; MAGUK, membrane associated guanylate kinase; MMP1, matrix metalloproteinase 1; HCC, hepatocellular carcinoma; PVTT, portal vein tumor thromb; mRNA, messenger RNA; PCR, polymerase chain reaction; SD, standard deviati
Keywords: کارسینوم هپاتوسلولار; hepatocellular carcinoma (HCC); percutaneous liver ablation (PLA); radiofrequency ablation (RFA)AFP, alpha feto protein; CT, computed tomography; HCC, hepatocellular carcinoma; HR, hepatic resection; PEI, percutaneous ethanol injection; PLA, percutaneous
Keywords: کارسینوم هپاتوسلولار; CI, confidence interval; CSF, colony-stimulating factor; HBsAg, hepatitis B virus surface antigen; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HR, Hazard Ratio; IL, Interleukin; IL-1B b, Interleukin-1 beta; IL-2, Interleukin-2; IL-4, Interleuki
Keywords: کارسینوم هپاتوسلولار; risk factor; HCC; aflatoxinAFB1, aflatoxin B1; DM, diabetes mellitus; GT, glucose tolerance; HBsAg, hepatitis-B surface antigen; HBV, Hepatitis B virus; HCC, hepatocellular carcinoma; HCV, Hepatitis C virus; IARC, International Agency for Research on Canc
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; FLC, fibrolamellar carcinoma; HR, hazard ratio; NCI, National Cancer Institute; OS, overall survival
Keywords: کارسینوم هپاتوسلولار; hepatitis B virus (HBV); hepatitis C (HCV); hepatocellular carcinoma (HCC)ACS, anorexia-cachexia syndrome; CBT, cognitive-behavioral therapy; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; QOL, quality of life; RT, radiothe
Keywords: کارسینوم هپاتوسلولار; HCC, Hepatocellular carcinoma; EPI, Epirubicin; NPs, nanoparticles; TNF-α, tumor necrosis factor-α; TBRAS, thiobarbituric acid reactive substances; NO, nitric oxide; SOF, superoxide dismutase; GSH, glutathione; ROS, reactive oxygen species; RES, reticuloe
Keywords: کارسینوم هپاتوسلولار; BPH, benign prostatic hyperplasia; BRMS1, breast cancer metastasis suppressor 1; COX-2, cyclooxygenase-2; CRC, colorectal cancer; EMT, epithelial-to-mesenchymal transition; GVHD, graft-versus-host disease; HCC, hepatocellular carcinoma; MMP, matrix metall
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; hTERT, human telomerase reverse transcriptase; hTR, human telomerase RNA; CND, cannabinoids; Δ9THC, tetrahydrocannabinol; CBD, cannabidiol; DMNA, dimethylnitrosamineHepatocellular carcinoma; Cannabis; mTERT; Caspase-8
Keywords: کارسینوم هپاتوسلولار; ApoC3, apolipoprotein C III; CK-18, cytokeratin-18; DAG, diacylglycerol; ER, endoplasmic reticulum; HCC, hepatocellular carcinoma; LPS, lipopolysaccharide; LXR, liver X receptor; MET, metabolic equivalent of task; NAFLD, nonalcoholic fatty liver disease;
Keywords: کارسینوم هپاتوسلولار; CI, respiratory complex I; CII, respiratory complex II; CS, citrate synthase; HCC, hepatocellular carcinoma; NAO, 10N-nonyl acridine orange; PCC, pump controlled cell rupture system; TTFA, thenoyltrifluoroacetoneMitochondria; Metabolic shift; Mitochondria
Keywords: کارسینوم هپاتوسلولار; BMI, body mass index; ChREBP, carbohydrate-responsive element-binding protein; DCA, deoxycholic acid; DMBA, dimethylbenz(a)anthracene; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HIF, hypoxia-inducible factor; IGF, insul
Keywords: کارسینوم هپاتوسلولار; NASH; Histology; Diagnosis; PrognosisAH, alcoholic hepatitis; ALD, alcoholic liver disease; HCC, hepatocellular carcinoma; IL, interleukin; K, keratin; MIR, microRNA; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis
Keywords: کارسینوم هپاتوسلولار; AML, acute myeloid leukemia; APC, antigen presenting cells; CTL, cytotoxic T lymphocyte; DAC, 5-aza-2′-deoxycytidine; DNMT1, DNA methyltransferase 1; HCC, hepatocellular carcinoma; IFN, interferon; IHC, immunohistochemistry; lnRNA, long non-coding RNA; MH
Keywords: کارسینوم هپاتوسلولار; ANOVA, Analysis of variance; CIs, Confidence intervals; ORs, Odds ratios; PCR, Polymerase chain reaction; RFLP, Restricted fragment length polymorphism; HCV, Hepatitis c virus; HCC, Hepatocellular carcinoma; FVL, Factor V Leiden; TSP-1, Thrombospondin-1Fa
Keywords: کارسینوم هپاتوسلولار; ACLF, acute-on-chronic liver failure; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ESRD, end stage renal disease; GI, gastrointestinal; Hb, hemoglobin; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; INR, international normalized
Keywords: کارسینوم هپاتوسلولار; abdominal thrombosis; hepatocellular carcinoma; cryptogenic cirrhosis; virus related cirrhosis; myeloproliferative neoplasmsAD, associated disease; BCS, Budd Chiarisyndrome; CT, cava thrombosis; HC, healthy controls; HCC, hepatocellular carcinoma; LC, liv
Keywords: کارسینوم هپاتوسلولار; BDTT, bile duct tumour thrombus; HCC, hepatocellular carcinoma; BCLC, Barcelona clinical liver cancer; RR, risk ratio; CI, confidence interval; NOS, Newcastle–Ottawa score
Keywords: کارسینوم هپاتوسلولار; HCC, Hepatocellular carcinoma; DNA, Deoxyribonucleic acid; mRNA, Messenger ribonucleic acid; AFP, Alpha feto protein; CEA, Carcinoembryonic antigen; MEIA, Microparticle enzyme immunoassay; PCR, Polymerase chain reaction; PCNA, Proliferating cell nuclear a
Keywords: کارسینوم هپاتوسلولار; Alpha fetoprotein; Circulating tumor cells; Metastasis; Hepatocellular carcinomaCTCs, circulating tumor cells; HCC, hepatocellular carcinoma; AFP, alpha fetoprotein; HepG2, hepatocellular carcinoma cell lines; EpCAM, epithelial cell adhesion molecule
Keywords: کارسینوم هپاتوسلولار; Aspergillus flavus; Aflatoxin; Arginine methylation; PRMT5; SDMAAFB1, aflatoxin B1; HCC, hepatocellular carcinoma; PRMT5, protein arginine methyltransferase 5; SDMA, symmetric dimethyl arginine; HaCaT, immortalized human keratinocytes; HepG2, human hepato
Keywords: کارسینوم هپاتوسلولار; BMI, body mass index; NAFLD, non-alcoholic fatty liver disease; HCC, hepatocellular carcinoma; ICD, international classification of disease; HR, hazard ratio; CI, confidence interval; NPR, National Patient Register; CDR, Causes of Death RegisterBody mass
Keywords: کارسینوم هپاتوسلولار; BMI, body mass index; CI, confidence interval; COX, cyclooxygenase; CPRD, Clinical Practice Research Datalink; GP, general practitioner; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; NSAID, Nonsteroidal anti-inflammatory d
Keywords: کارسینوم هپاتوسلولار; CHB, chronic hepatitis B; HCC, hepatocellular carcinoma; IFN, interferon; HBV, hepatitis B virus; PEG-IFNa-2a, peginterferon alfa-2a; OR, odds ratio; CI, confidence intervals; RCT, randomized controlled trials
Keywords: کارسینوم هپاتوسلولار; NAFLD; ALD; MortalityAAH, acute alcoholic hepatitis; ALD, alcoholic fatty liver disease; BMI, body mass index; HCC, hepatocellular carcinoma; HRQL, health-related quality of life; NAFLD, nonalcoholic fatty liver disease; NHANES, National Health and Nutrit
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C virus; HR, hazard ratio; NASH, nonalcoholic steatohepatitis; sVEGFR1, soluble vascular endothelial growth factor receptor 1; sVEGFR2, soluble vascular endothelial growth factor recept
Keywords: کارسینوم هپاتوسلولار; Computed tomography; Dual energy CT; Liver tumors; Renal tumors; Urinary stonesCT, computed tomography; DECT, dual-energy computed tomography; HU, Hounsfield unit; HCC, hepatocellular carcinoma; GIST, gastrointestinal stromal tumor; NET, neuroendocrine tu
Inflammatory pseudotumor of the liver occurring during the course of hepatitis C virus-related hepatocellular carcinoma treatment: A case report
Keywords: کارسینوم هپاتوسلولار; IPT, inflammatory pseudotumor; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; CT, computed tomography; CRP, C-reactive protein; AFP, alpha-fetoprotein; PIVKA-II, protein induced by vitamin K absence-2; SOL, space-occupying lesion; CTHA, CT hepatic
High-throughput screening of Sirtuin family of genes in breast cancer
Keywords: کارسینوم هپاتوسلولار; BC, breast cancer; cDNA, complementary DNA; DMEM, Dulbecco's modified eagle's medium; FBS, fetal bovine serum; NAD, nicotinamide adenine dinucleotide; HDACs, histone deacetylases; HNSCC, head and neck squamous cell carcinoma; HCC, hepatocellular carcinoma
RASSF1A, RECK genotypes and haplotypes in Egyptian population with Hepatocellular carcinoma
Keywords: کارسینوم هپاتوسلولار; HCC, Hepatocellular carcinoma; RASSF, Ras association domain family; RECK, reversion-inducing-cysteine-rich protein with Kazal motifs; T.bil, total bilirubin; AFP, Alpha fetoprotein; Hb, Hemoglobin; ALT, alanine transeferase; AST, aspartate transferaseHep
Multi-detector CT perfusion as a diagnostic imaging modality to evaluate local therapy of hepatocellular carcinoma
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; RFA, radiofrequency ablation; TACE, trans-arterial chemoembolization; TDC, time density curve; CTP, volume perfusion MDCT
Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis
Keywords: کارسینوم هپاتوسلولار; lncRNA, long noncoding RNA; HCC, hepatocellular carcinoma; SNHG1, small nucleolar RNA host gene 1; qRT-PCR, quantitative real-time polymerase chain reaction; siRNA, small interfering RNA; CCK-8, Cell Counting Kit-8; BCLC, Barcelona Clinic Liver Cancer; HB
Diffusion-weighted MR imaging of non-complicated hepatic cysts: Value of 3T computed diffusion-weighted imaging
Keywords: کارسینوم هپاتوسلولار; DWI, diffusion-weighted imaging; MRI, magnetic resonance imaging; SI, signal intensity; HCC, hepatocellular carcinoma; SNR, signal-to-noise ratio; c-DWI, computed diffusion-weighted imaging; T1-WI, T1-weighted MRI; T2-WI, T2-weighted MRI; ADC, apparent di
How should hyperferritinaemia be investigated and managed?
Keywords: کارسینوم هپاتوسلولار; SF, serum ferritin; HH, hereditary haemochromatosis; NAFLD, non-alcoholic fatty liver disease; HCC, hepatocellular carcinoma; TS, transferrin saturation; HJV, hemojuvelin; NASH, non-alcoholic hepatic steatohepatitis; HHCS, hereditary hyperferritinaemia-ca
Studies on the biological functions of CPS1 in AFB1 induced hepatocarcinogenesis
Keywords: کارسینوم هپاتوسلولار; CPS1, carbamyl phosphate synthetase 1; AFB1, aflatoxin B1; HCC, hepatocellular carcinoma; siRNA, s mall interfering RNA; Co-IP, Co-immunoprecipitation; KRT1, Keratin I, ALB albumin; CYPs, cytochromes P450; GDH, glutamate dehydrogenase; AST, aspartate tran
miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; miRNA, microRNA; TCGA, the Caner Genome Atlas project; GEO, Gene Expression Omnibus; HMGA2, high mobility group A2; 3′-UTR, 3′ untranslated region; mRNA, message RNA; EMT, epithelial-to-mesenchymal transitionHepatocellular c
Overexpression of DLX2 is associated with poor prognosis and sorafenib resistance in hepatocellular carcinoma
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; PCNA, proliferating cell nuclear antigen; DLX2, distal-less homeobox 2; TGF-β, transforming growth factor-β; EGFR, epidermal growth factor receptor; ERK, extracellular signal-regulated protein kinase; EMT, epithelial–mesench
Low incidence of acute rejection in hepatitis B virus positive liver transplant recipients and the impact of hepatitis B immunoglobulin
Keywords: کارسینوم هپاتوسلولار; HBV, Hepatitis B virus; HCV, Hepatitis C virus; LT, liver transplantation; HBIG, Hepatitis B immunoglobulin; ACR, acute cellular rejection; HCC, hepatocellular carcinoma; IVIG, intravenous immunoglobulin; OPTN, Organ Procurement and Transplantation Networ
Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model
Keywords: کارسینوم هپاتوسلولار; Autoimmune hepatitis; NAFLD; CYP2D6; Mouse model; Hepatic fibrosisNAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; HCC, hepatocellular carcinoma; AIH, autoimmune hepatitis; CYP2D6, cytochrome P450 2D6; LKM-1, type 1 liver/kid
Nanosecond pulsed electric field (nsPEF) enhance cytotoxicity of cisplatin to hepatocellular cells by microdomain disruption on plasma membrane
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; nsPEF, nanosecond pulsed electric field; PI, propidium iodide; EDS, energy dispersive X-ray spectroscopyNanosecond pulsed electric field (nsPEF); Cisplatin; Cationized ferritin; Energy dispersive X-ray spectroscopy (EDS)
PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression
Keywords: کارسینوم هپاتوسلولار; PTD; p53; Antiviral; HBVCHB, chronic hepatitis B; HCC, hepatocellular carcinoma; IFN-α, alpha interferon; cccDNA, covalently closed circular DNA; ORFs, open reading frames; TAT, trans-activator of transcription; PTD, protein transduction domain of trans-a
The PDGF system and its antagonists in liver fibrosis
Keywords: کارسینوم هپاتوسلولار; α-SMA, α-smooth muscle actin; α2M, α-2-macroglobulin; BDL, bile duct ligation; Con A, concanavalin A; DMN, dimethylnitrosamine; ECM, extracellular matrix; FSAP, factor VII-activating protease; HCC, hepatocellular carcinoma; HSC, hepatic stellate cell(s);
Limited Fibrosis Progression but Significant Mortality in Patients Ineligible for Interferon-Based Hepatitis C Therapy
Keywords: کارسینوم هپاتوسلولار; AA, African-American; APRI, aspartate-aminotransferase-to-platelet ratio index; DTB, dominant treatment barrier; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; SVR, sustained virologic responsehepatitis C; treatment barrier; liver fibrosis; progre
Downregulation of Peptidylprolyl isomerase A promotes cell death and enhances doxorubicin-induced apoptosis in hepatocellular carcinoma
Keywords: کارسینوم هپاتوسلولار; PPIA, Peptidylprolyl isomerase A; HCC, hepatocellular carcinoma; ELISA, Enzyme linked immunosorbent assay; Bcl-2, B-cell CLL/lymphoma 2; Bcl-xL, BCL2-like 1Hepatocellular carcinoma; Peptidylprolyl isomerase A; Apoptosis; Cell growth; Doxorubicin
Histone deacetylase inhibitors reduce WB-F344 oval cell viability and migration capability by suppressing AKT/mTOR signaling in vitro
Keywords: کارسینوم هپاتوسلولار; Oval cells; AKT/mTOR signaling pathway; Histone deacetylase inhibitor; Rapamycin; Cell proliferation; ApoptosisHDAC, Histone deacetylase; SAHA, suberoylanilidehydroxamic acid; TSA, trichostatin-A; HCC, hepatocellular carcinoma; AKT, Protein Kinase B; mTOR
SALL4, the missing link between stem cells, development and cancer
Keywords: کارسینوم هپاتوسلولار; ESCs, embryonic stem cells; SALL, Spalt-like; C2H2, Cys(2)his(2); Q, glutamine; ZF, zinc finger; AAs, amino acids; ICM, inner cell mass; HSPCs, hematopoietic stem/progenitor cells; PND7, postnatal day 7; HCC, hepatocellular carcinoma; CDX1, caudal-related